AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Apyx Medical Corporation has priced an underwritten public offering of 2.76 million shares of common stock at $3.62 per share. The offering is expected to close on November 19, 2025, and the underwriter has a 45-day option to purchase an additional 414,365 shares. The offering will be sold by the Company, and Lucid Capital Markets is acting as the sole book-running manager.
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet